BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26709219)

  • 1. An aza-anthrapyrazole negatively regulates Th1 activity and suppresses experimental autoimmune encephalomyelitis.
    Clark MP; Leaman DW; Hazelhurst LA; Hwang ES; Quinn A
    Int Immunopharmacol; 2016 Feb; 31():74-87. PubMed ID: 26709219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel aza-anthrapyrazole blocks the progression of experimental autoimmune encephalomyelitis after the priming of autoimmunity.
    Kiraly A; Koffman B; Hacker M; Gunning W; Rasche S; Quinn A
    Clin Immunol; 2011 Dec; 141(3):304-16. PubMed ID: 21964417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
    Nath N; Giri S; Prasad R; Salem ML; Singh AK; Singh I
    J Immunol; 2005 Jul; 175(1):566-74. PubMed ID: 15972693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells.
    Hwang I; Ahn G; Park E; Ha D; Song JY; Jee Y
    Immunol Lett; 2011 Aug; 138(2):169-78. PubMed ID: 21524666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy.
    Nath N; Giri S; Prasad R; Singh AK; Singh I
    J Immunol; 2004 Jan; 172(2):1273-86. PubMed ID: 14707106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
    Lee J; Choi J; Lee W; Ko K; Kim S
    Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
    Haghmorad D; Amini AA; Mahmoudi MB; Rastin M; Hosseini M; Mahmoudi M
    J Neuroimmunol; 2014 Dec; 277(1-2):85-95. PubMed ID: 25457839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents.
    Dinter H; Tse J; Halks-Miller M; Asarnow D; Onuffer J; Faulds D; Mitrovic B; Kirsch G; Laurent H; Esperling P; Seidelmann D; Ottow E; Schneider H; Tuohy VK; Wachtel H; Perez HD
    J Neuroimmunol; 2000 Aug; 108(1-2):136-46. PubMed ID: 10900347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
    Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
    Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting macrophages by an aza-anthrapyrazole to ameliorate experimental autoimmune encephalomyelitis.
    Lin B; Launder D; Bailey DY; Assifuah FK; Miller OA; Conti HR; Du J; Koffman BM
    Mult Scler Relat Disord; 2020 Aug; 43():102190. PubMed ID: 32447250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
    Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.
    Kato H; Ito A; Kawanokuchi J; Jin S; Mizuno T; Ojika K; Ueda R; Suzumura A
    Mult Scler; 2004 Dec; 10(6):651-9. PubMed ID: 15584490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway.
    You Z; Timilshina M; Jeong BS; Chang JH
    Eur J Immunol; 2017 Sep; 47(9):1488-1500. PubMed ID: 28681958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, regulates differentiation of Th1 and Th17 cells to ameliorate experimental autoimmune encephalomyelitis.
    Kang Y; Timilshina M; Nam TG; Jeong BS; Chang JH
    Biol Res; 2017 Feb; 50(1):8. PubMed ID: 28241881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity.
    Gocke AR; Cravens PD; Ben LH; Hussain RZ; Northrop SC; Racke MK; Lovett-Racke AE
    J Immunol; 2007 Feb; 178(3):1341-8. PubMed ID: 17237380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.